Hohimer Wealth Management
ABBV icon

Hohimer Wealth Management’s AbbVie ABBV Stock Holding History

Hohimer Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$543K Buy
2,076
+27
+1% +$6.92K 0.05% 220
2026
Q2 		$516K Buy
2,049
+8
+0.4% +$1.72K 0.05% 223
2026
Q1 		$444K Buy
2,041
+145
+8% +$32.2K 0.05% 215
2025
Q4 		$433K Hold
1,896
– – 0.06% 198
2025
Q3 		$439K Hold
1,896
– – 0.06% 201
2025
Q2 		$352K Buy
1,896
+1
+0.1% +$186 0.06% 173
2025
Q1 		$397K Buy
1,895
+359
+23% +$69.8K 0.08% 177
2024
Q4 		$273K Buy
1,536
+104
+7% +$19.1K 0.05% 189
2024
Q3 		$283K Buy
1,432
+160
+13% +$29.9K 0.06% 176
2024
Q2 		$218K Sell
1,272
-1
-0.1% -$166 0.05% 202
2024
Q1 		$232K Buy
+1,273
New +$219K 0.05% 210
2023
Q1 		– Sell
-25,683
Closed -$4.15M – 195
2022
Q4 		$4.15M Buy
25,683
+3,889
+18% +$596K 1.32% 18
2022
Q3 		$2.92M Buy
21,794
+327
+2% +$46.9K 0.94% 38
2022
Q2 		$3.29M Sell
21,467
-10,889
-34% -$1.66M 0.97% 38
2022
Q1 		$5.24M Buy
32,356
+1,457
+5% +$212K 1.03% 24
2021
Q4 		$4.18M Buy
30,899
+19
+0.1% +$2.24K 0.88% 30
2021
Q3 		$3.33M Buy
30,880
+626
+2% +$71.5K 0.7% 54
2021
Q2 		$3.41M Buy
30,254
+1,856
+7% +$209K 0.7% 55
2021
Q1 		$3.07M Buy
28,398
+2,842
+11% +$304K 0.75% 45
2020
Q4 		$2.74M Buy
25,556
+311
+1% +$29.9K 0.73% 41
2020
Q3 		$2.13M Sell
25,245
-436
-2% -$41K 0.61% 51
2020
Q2 		$2.52M Sell
25,681
-1,626
-6% -$143K 0.87% 33
2020
Q1 		$2.31M Buy
27,307
+5,005
+22% +$426K 0.98% 27
2019
Q4 		$1.98M Buy
+22,302
New +$1.85M 0.69% 43

Other funds holding ABBV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Hohimer Wealth Management's ABBV Position: Q3 2026 in Review

Hohimer Wealth Management increased its AbbVie (ABBV) stake by 1.3% in Q3 2026, buying an estimated $6.92K and bringing the position to 2,076 shares worth $543K. The position accounts for 0.05% of the portfolio, ranked #220.

Hohimer Wealth Management first reported a position in ABBV in Q4 2019 and has held it in 24 quarters since. The position peaked at $5.24M in Q1 2022. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Hohimer Wealth Management held 2,076 shares of AbbVie worth $543K as of Q3 2026.
  • Hohimer Wealth Management bought 27 AbbVie shares in Q3 2026, an estimated $6.92K.
  • AbbVie made up 0.05% of Hohimer Wealth Management's portfolio in Q3 2026, its #220 holding.
  • Hohimer Wealth Management first reported a position in AbbVie in Q4 2019 and has held it in 24 quarters since.
  • Hohimer Wealth Management's AbbVie position peaked at $5.24M in Q1 2022.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Hohimer Wealth Management's 13F filing for Q3 2026, filed 2 Nov 2026.